Genetic variation of CYP2A6, smoking, and risk of cancer
- 1 March 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 353 (9156) , 898-899
- https://doi.org/10.1016/s0140-6736(98)04984-8
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Nicotine metabolism defect reduces smokingNature, 1998
- Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomesCarcinogenesis: Integrative Cancer Research, 1992
- Human cytochrome P450IIA3: cDNA sequence role of the enzyme in the metabolic of promutagens comparison to nitrosamine activation by human cytochrome P450IIE1Carcinogenesis: Integrative Cancer Research, 1990